GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Issuance of Debt

TaiMed Biologics (ROCO:4147) Issuance of Debt : NT$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Issuance of Debt?

TaiMed Biologics's Issuance of Debt for the three months ended in Dec. 2024 was NT$0.0 Mil.

TaiMed Biologics's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.0 Mil.


TaiMed Biologics Issuance of Debt Historical Data

The historical data trend for TaiMed Biologics's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Issuance of Debt Chart

TaiMed Biologics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 536.00 - 200.00 - -200.00

TaiMed Biologics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TaiMed Biologics Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiMed Biologics Issuance of Debt Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiMed Biologics Business Description

Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others. It earns revenue from sale of medicines and by providing contract testing and development services for biopharmaceuticals.

TaiMed Biologics Headlines

No Headlines